Aflatoxin B1 is not a minor agricultural nuisance. Produced by Aspergillus flavus and its close relative Aspergillus parasiticus, the compound routinely contaminates maize, peanuts, tree nuts, and other commodities, and chronic dietary exposure is strongly linked to hepatocellular carcinoma, particularly in regions where food security infrastructure is limited. Regulatory agencies worldwide enforce strict limits on aflatoxin levels in food and feed, yet controlling the fungus in the field and during storage remains an uphill battle. Understanding the internal circuitry that switches toxin production on and off has therefore been a central goal of mycotoxin research for decades, and the new study adds a critical piece to that puzzle: the fungus appears to read its iron environment through AflHapX and adjust its toxin output accordingly.

The team began by searching the A. flavus genome using the protein sequence of HapX from Aspergillus fumigatus, a well-characterized iron regulator in that pathogenic mold. This bioinformatic fishing expedition pulled out AflHapX, a bZIP-type transcription factor belonging to a family of proteins that bind DNA through a basic leucine zipper domain. To determine what the gene actually does, the researchers turned to homologous recombination, a technique that allows precise replacement of a target gene with a selectable marker. Using this approach, they constructed a deletion strain lacking AflhapX, as well as a complemented strain in which the gene was restored. This trio of strains, wild type, deletion mutant, and complemented control, forms the gold-standard experimental design for establishing that an observed phenotype is genuinely caused by the gene in question rather than by off-target effects of the genetic manipulation.

The first major result concerned aflatoxin production under standard laboratory conditions. When equal numbers of spores, or conidia, from the three strains were inoculated onto YES medium and incubated for seven days at 29 degrees Celsius, the deletion mutant produced significantly less aflatoxin B1 than both the wild type and the complemented strain, as measured by thin-layer chromatography. This straightforward observation established AflHapX as a positive regulator of toxin biosynthesis. But the more striking discovery came when the researchers manipulated iron availability in the culture environment, growing the wild-type and mutant strains under iron-sufficient, iron-starved, and iron-excess conditions and comparing toxin output across all six combinations.

The pattern that emerged was anything but simple. In the deletion mutant, aflatoxin B1 production was highest under iron excess, intermediate under iron sufficiency, and lowest under iron starvation. The wild type showed precisely the opposite relationship, producing more toxin when iron was scarce and less when iron was abundant. In other words, removing AflHapX inverted the fungus’s iron-to-toxin relationship, a result that strongly suggests the transcription factor is the conduit through which iron availability is translated into changes in aflatoxin biosynthesis. The authors conclude that AflHapX regulates AFB1 production through the iron homeostasis pathway, effectively coupling a fundamental nutrient-sensing system to a virulence and contamination trait of enormous economic and public health importance.

Iron is a double-edged nutrient for fungi. It is essential as a cofactor for enzymes involved in respiration, DNA synthesis, and detoxification, yet excess iron catalyzes the formation of destructive hydroxyl radicals through the Fenton reaction. Filamentous fungi therefore maintain elaborate iron regulatory networks, and in Aspergillus species the HapX protein sits at the center of that network, working with the CCAAT-binding complex to repress or activate genes depending on whether iron is scarce or plentiful. The new study demonstrates that in A. flavus this ancient homeostatic machinery does not merely manage iron metabolism; it also feeds into the regulation of secondary metabolism, the branch of fungal chemistry responsible for aflatoxins and numerous other bioactive compounds.

Beyond toxin production, the deletion of AflhapX produced a constellation of other phenotypes that flesh out the protein’s biological role. Mutant strains formed more sclerotia, the compact survival structures that A. flavus uses to persist in soil and overwinter between cropping seasons, hinting that iron signaling may also influence the fungus’s environmental survival strategy. The mutant was also markedly more sensitive to oxidative stress reagents, including hydrogen peroxide, menadione sodium bisulfite, and diamide, indicating that AflHapX helps the fungus cope with reactive oxygen species. This connection is particularly intriguing because oxidative stress is known to influence aflatoxin biosynthesis, and because the host plant itself generates oxidative bursts as a defense against fungal invasion.

To move from single-gene observations to a genome-wide picture, the team performed RNA sequencing on the wild-type and deletion strains. The transcriptome data revealed that AflHapX acts globally at the transcriptional level, coordinating the expression of genes involved in iron homeostasis, aflatoxin biosynthesis, and oxidative stress responses. This systems-level view confirms that the phenotypes observed in the plate assays reflect broad transcriptional rewiring rather than isolated changes, and it provides a catalog of downstream targets that other laboratories can now mine for additional regulatory connections.

The practical significance of the work was tested on the crop itself. When the wild-type, deletion, and complemented strains were inoculated onto peanut seeds, the deletion mutant produced fewer conidia and less aflatoxin B1 than the other two strains. Peanuts are among the crops most vulnerable to A. flavus infection, and the reduced growth and toxin output of the mutant on seeds suggests that AflHapX contributes to the fungus’s fitness in its natural agricultural niche, not just under laboratory conditions.

Professor Wang summarized the implications, stating that the findings demonstrate AflHapX serves as a key regulator coupling iron availability and aflatoxin B1 biosynthesis in A. flavus, and that the study provides new insights into the interplay between environmental iron and mycotoxin production, with potential implications for understanding the regulatory mechanisms of aflatoxin contamination in agricultural products. The prospect of targeting an iron-sensing pathway to suppress toxin production opens a genuinely novel intervention strategy. Iron availability in stored grain and processed commodities is an environmental variable that could, in principle, be managed through storage practices, biofortification approaches, or the development of compounds that disrupt AflHapX function. Because the deletion mutant also shows reduced sporulation on seeds, interfering with this pathway might simultaneously limit both the spread of the fungus and its chemical arsenal. The research also raises questions that extend well beyond a single species: if nutrient sensing and secondary metabolism are cross-wired in A. flavus, similar regulatory couplings may operate in other pathogenic and toxigenic fungi worldwide, offering a general principle for future antifungal and antitoxin strategies.

Subject of Research: Iron homeostasis and aflatoxin biosynthesis regulation by the transcription factor AflHapX in Aspergillus flavus

Article Title: bZIP transcription factor AflHapX coordinates iron homeostasis and aflatoxin biosynthesis in Aspergillus flavus

Article References: bZIP transcription factor AflHapX coordinates iron homeostasis and aflatoxin biosynthesis in Aspergillus flavus. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: Aspergillus flavus, AflHapX, aflatoxin B1, iron homeostasis, bZIP transcription factor, mycotoxin, transcriptomics, oxidative stress, sclerotia, peanut contamination, food safety, fungal biology

The significance of the findings begins with the crop itself. Mung bean, originally domesticated in India, is now cultivated on roughly 7.3 million hectares globally, producing an estimated 6 million tons annually, with India, Myanmar, China, and Indonesia dominating the market. As a legume, it fixes atmospheric nitrogen through symbiosis with rhizobia, improving soil fertility and providing nitrogen inputs for subsequent crops, which makes it especially valuable in resource-limited farming systems. In Ethiopia, mung bean is an emerging crop concentrated in the North Shewa and South Wollo zones of the Amhara region and parts of Benishangul-Gumuz. Yet productivity remains stubbornly low: traditional varieties average about 0.5 megagrams per hectare, improved varieties can exceed 1.5 megagrams under optimal conditions, and the national average of 0.9 megagrams per hectare sits roughly 20 percent below the world average. Unpredictable rainfall, fungal pathogens, pests, poor agronomic practices, and limited access to quality inputs all conspire to hold yields back.

That combination of biotic and abiotic pressures is precisely where endophytic bacteria enter the picture. Endophytes are microorganisms that live within plant tissues without causing disease, and they can benefit their hosts in two broad ways. Direct growth promotion occurs through the production of phytohormones, improved nutrient mobilization, and the induction of systemic tolerance to environmental stress. Indirect protection comes through competitive exclusion of pathogens and the secretion of antimicrobial metabolites such as lipopeptides, polyketides, and volatile organic compounds. Fungal pathogens like Aspergillus flavus pose a particularly serious threat because they produce aflatoxins that contaminate seeds and endanger human and animal health, making biocontrol agents that can target this fungus a priority for both food security and food safety.

To find candidate microbes, the team grew fifty Shewa-type mung bean seeds in vertisol soil at Addis Ababa Science and Technology University without any chemical fertilizers, irrigating weekly over three months until the plants reached the fruiting stage. They then collected fifty healthy root systems and fifty seeds and subjected them to a rigorous surface sterilization protocol involving sequential ethanol and sodium hypochlorite treatments. Crucially, the researchers validated the sterilization using two complementary methods: imprinting sterilized tissues onto nutrient agar plates and spread-plating the final rinse water. Only samples showing zero visible microbial growth after overnight incubation were used, ensuring that the bacteria recovered genuinely lived inside the plant tissues rather than on their surfaces. Macerated tissues were serially diluted and spread across four different growth media to capture as broad a range of the culturable endophytic community as possible.

The isolation effort yielded twenty-eight distinct bacterial endophytes, with more recovered from seeds, sixteen, than from roots, twelve, a distribution suggesting that seed-associated microbiomes may facilitate vertical transmission of beneficial bacteria across generations. Eight representative isolates, selected for their morphological diversity and labeled GMB R1, R2, S1 through S6, were chosen for detailed characterization. Biochemical profiling revealed that three isolates were Gram-positive while five were Gram-negative, all produced catalase, and all fermented glucose. Stress tolerance screening then uncovered a striking spectrum of resilience. Four isolates, GMB R1, R2, S5, and S6, showed robust thermotolerance, maintaining optical densities above 0.58 at 45 degrees Celsius, while others were thermosensitive and grew poorly above 37 degrees. GMB R2 displayed exceptional pH flexibility, losing less than 15 percent growth across the full range from pH 4 to pH 10, and GMB S5 proved the strongest halotolerant strain, sustaining growth at sodium chloride concentrations as high as 12 percent.

Heavy metal tolerance added another dimension to the functional portrait. When grown in media amended with lead acetate at concentrations from 50 to 300 micrograms per milliliter, all isolates grew at the baseline level, but growth inhibition increased with concentration in a strain-dependent manner. GMB R1 stood out as the most lead-tolerant, maintaining strong optical density across the entire gradient, with GMB R2 and GMB S5 close behind. The authors suggest that mechanisms such as exopolysaccharide production, metal sequestration, and efflux systems likely underpin this tolerance, and they highlight the strains as candidates for colonizing plants in heavy metal-contaminated agricultural soils, a growing problem in many intensively farmed regions.

The biocontrol results may prove the most immediately compelling. In dual culture assays on malt extract agar, GMB R1 and GMB R2 significantly suppressed Aspergillus flavus, reducing fungal mycelial growth by 66.7 percent and 73.3 percent respectively, compared with control colony diameters of 4.5 millimeters after seven days. Enzymatic profiling revealed strain-specific specialization that could contribute to this antagonism: GMB R1 showed the highest cellulase activity with an enzymatic index of 2.5, GMB R2 the highest chitinase activity at 1.6, and GMB S5 the highest protease activity at 2.0. Chitinase is particularly relevant to antifungal action because chitin is a structural component of fungal cell walls. Siderophore production, which starves pathogens of iron, was detected in seven of the eight isolates, and six isolates produced ACC deaminase, an enzyme that lowers plant ethylene levels and helps seedlings withstand stress. Notably, the study found no trade-off between stress adaptation and biocontrol capacity, meaning the hardiest strains were also among the best fungal antagonists.

Molecular identification using 16S rRNA gene sequencing confirmed the taxonomy of three key isolates: GMB R1 matched Pseudomonas fluorescens with 99.87 percent similarity, GMB R2 showed 100 percent identity with Pantoea agglomerans, and GMB S5 aligned fully with Serratia marcescens. Sequencing failed for the remaining five isolates, likely due to suboptimal DNA template quality, so those strains are currently identified only by morphological and biochemical profiles, a limitation the authors candidly acknowledge. Partial 16S rRNA sequences for the three characterized strains have been deposited in NCBI GenBank under accession numbers OR974898.1, OR974899.1, and OR974900.1, and phylogenetic analysis using the maximum-likelihood method with 1,000 bootstrap replicates supported their taxonomic placements.

Perhaps the most eye-catching numbers come from the plant growth assays, conducted not on mung bean itself but on wheat (Triticum aestivum) and rapeseed (Brassica napus), demonstrating cross-host efficacy. In germination tests, GMB S6 increased wheat seedling radicle length to 12.4 centimeters and plumule extension to 18.9 centimeters, producing a vigor index of 3,067.4, roughly 140 percent above the uninoculated control. In pot trials over 90 days, GMB S5 produced wheat roots 77 percent longer than controls with an 85 percent increase in root dry weight. On rapeseed, GMB R1 extended radicle length by 149 percent and achieved a vigor index of 2,114.6, an 82 percent improvement, while GMB R2 generated the longest plumules at 9.1 centimeters and boosted rapeseed plumule length by 127 percent. Germination rates stayed high across all treatments, between 94 and 97 percent, indicating that the bacteria enhanced post-germinative development rather than germination itself. One isolate, GMB S2, actually inhibited plumule growth, a reminder that endophyte effects are strain- and context-dependent and that not every endophyte is benign or beneficial.

The authors are careful to frame the work as an exploratory baseline rather than a field-ready prescription. The sampling came from a single site and a single cultivar, physiological assays relied on optical density rather than viable cell counts, heavy metal testing used only lead as a model contaminant, and the inoculated bacteria were not re-isolated from wheat and rapeseed tissues to confirm true endophytic establishment. Field conditions, with competition from indigenous microbiota and environmental variability, will likely produce more modest gains than the laboratory and greenhouse results suggest. Still, the combination of thermotolerance, halotolerance, heavy metal resistance, siderophore production, lytic enzymes, ACC deaminase activity, antifungal activity against aflatoxigenic fungi, and cross-host growth promotion makes GMB R1, GMB R2, and GMB S5 stand out as promising multifunctional bioinoculants. Future work, including whole-genome sequencing, testing on the native mung bean host, consortium design, and multi-location randomized field trials, will determine whether these Ethiopian endophytes can translate their laboratory performance into real yields for marginal agroecosystems, where the need for sustainable alternatives to chemical inputs has never been greater.

Subject of Research: Stress-tolerant endophytic bacteria isolated from Ethiopian mung bean with biocontrol and plant growth-promoting traits

Article Title: Stress-resilient endophytic bacteria from mung bean (Vigna radiata L.) with biocontrol and plant growth-promoting potential

Article References: Abatenh, E., Kebede, M., & Abda, E. M. (2026). Stress-resilient endophytic bacteria from mung bean (Vigna radiata L.) with biocontrol and plant growth-promoting potential. International Microbiology. https://doi.org/10.1007/s10123-026-00897-y

Image Credits: AI Generated

DOI: 10.1007/s10123-026-00897-y

Keywords: endophytic bacteria, mung bean, Vigna radiata, biocontrol, Aspergillus flavus, plant growth promotion, Pseudomonas fluorescens, Pantoea agglomerans, Serratia marcescens, abiotic stress tolerance, aflatoxin, sustainable agriculture

The concept of mining fungi for medicinal compounds is not new—antibiotics like penicillin owe their origins to fungal metabolites—but the curative promise of RiPPs in fungi has remained largely untapped until now. Fungal RiPPs present a unique biosynthetic challenge due to their complex synthesis pathways, distinctly different from the well-studied bacterial counterparts. These peptides are synthesized directly by ribosomes before undergoing intricate post-translational modifications that bestow them with enhanced pharmaceutical properties. The rarity and difficulty in purifying these molecules have historically hampered their integration into drug discovery, yet the meticulous work by this research team breaks new ground by uncovering a previously unknown assembly of RiPPs, termed asperigimycins, characterized by their exceptional heptacyclic benzofuranoindoline frameworks.

A. flavus, apart from its historical notoriety, harbors gene clusters previously elusive to researchers. Employing a combined approach of gene knockout experiments and mass spectrometry-based metabolic profiling, the team deciphered the genetic underpinnings responsible for RiPP biosynthesis in the fungus. This strategy allowed them to conclusively link specific proteins to the production of bioactive asperigimycins, while demonstrating that disabling these genes eradicated the signature chemical markers of these compounds in fungal cultures. Such integration of genetic and metabolomic data not only illuminated fungal RiPP biosynthesis but also set a methodological precedent for identifying novel natural products across other pathogenic or symbiotic fungi.

The purified asperigimycins exhibited remarkable anticancer activity in vitro, focusing primarily on leukemia cell lines. Two of the four distinct asperigimycin variants revealed significant cytotoxic effects without any chemical modification, underscoring their potential as lead compounds in drug development. Intriguingly, one variant modified with a lipid moiety analogous to components found in royal jelly—a nutrient-rich secretion essential for bee larvae development—demonstrated comparable efficacy to cytarabine and daunorubicin, both cornerstone drugs in leukemia treatment. This lipid conjugation not only increased potency but also highlighted a novel avenue to enhance cellular uptake and bioavailability of cyclic peptides, traditionally hindered by their large, complex structures.

Delving deeper into the mechanisms governing cellular entry, the researchers pinpointed a gene named SLC46A3 within leukemia cells that plays a pivotal role in facilitating the transport of asperigimycins from lysosomal compartments into the cytosol. This transporter’s gating function appears critical for the compounds’ therapeutic effects, suggesting that lipid modification may optimize the interaction with SLC46A3, thereby amplifying intracellular concentrations of the bioactive molecules. This insight unveils a new paradigm in drug design where modifying natural product structures to exploit endogenous trafficking pathways could revolutionize the delivery efficiency of cyclic peptide-based drugs.

Further mechanistic investigations revealed that asperigimycins exert their anticancer effects through disruption of microtubule dynamics, an essential process for mitotic cell division. By binding to components involved in microtubule polymerization, these fungal RiPPs selectively inhibit the proliferation of leukemia cells, sparing other cancer types and non-cancerous cells alike. This specificity is a breakthrough in targeted therapy, minimizing off-target effects and toxicity—a significant challenge with existing chemotherapy agents. Such precision medicine, built on natural product scaffolds, promises to enhance patient outcomes while reducing side effects.

Another compelling aspect of this discovery is the fungus’s restriction of asperigimycins’ activity spectrum, which includes no observed antibacterial or antifungal effects. This delineation hints at a sophisticated biological interaction, where these molecules have evolved to target specific eukaryotic cellular pathways, possibly as a defense mechanism in natural environments. Understanding this evolutionary context enriches drug discovery by providing clues on molecular specificity and guiding structural modification strategies to fine-tune pharmacological targets.

The potential ripple effects of this study extend beyond A. flavus. The team identified analogous gene clusters across various fungal species, implying a vast, untapped reservoir of RiPPs with diverse bioactive profiles awaiting exploration. Given the emerging significance of cyclic peptides in pharmaceutical pipelines—nearly two dozen have achieved clinical approval since 2000—this fungal RiPP frontier represents a propitious field for next-generation therapeutics. Exploiting fungal biodiversity could dramatically expand the chemical space accessible for drug design, inspiring multidisciplinary collaborations across synthetic biology, medicinal chemistry, and oncology.

The researchers stress that their next milestones involve in vivo testing of asperigimycins to evaluate pharmacokinetics, bioavailability, and safety profiles within animal models. Success in these stages could pave the path towards human clinical trials and eventual incorporation into cancer treatment regimens. Concurrently, the deeper understanding of transport genes like SLC46A3 opens avenues for companion diagnostics, allowing the identification of patient subsets most likely to benefit from RiPP-based therapies, fostering personalized medicine.

As this research exemplifies the creative potential of revisiting long-dreaded microorganisms, it underscores nature’s enduring capacity to inspire innovative solutions to complex diseases. The transformation of Aspergillus flavus from an agent of historical calamity into a beacon of therapeutic hope highlights how integrative science—melding molecular biology, chemical engineering, and pharmacology—can turn ancient microbial curses into modern cures. In the words of Professor Sherry Gao, “Nature has given us this incredible pharmacy. It’s up to us to uncover its secrets.”

This pioneering work was accomplished through a collaborative effort incorporating institutions including the University of Pennsylvania School of Engineering and Applied Science, Rice University, the University of Pittsburgh, MD Anderson Cancer Center, Washington University School of Medicine, Baylor College of Medicine, and the University of Porto. Supported by a spectrum of federal and private funding bodies, the research advances not only scientific understanding but also intellectual property, with a provisional patent application filed to safeguard the novel chemical entities discovered.

As researchers continue to harness fungal RiPPs’ unexplored diversity, the implications for cancer therapy, and potentially other disease areas, become profound. This breakthrough invites the scientific community to revisit and rethink natural product-based drug discovery, especially in underexplored domains harboring biologically unprecedented molecules. The advent of asperigimycins symbolizes a leap forward, offering hope for more efficient, targeted, and less toxic cancer treatments crafted in the crucible of fungal biochemistry.

Subject of Research: Cells

Article Title: A class of benzofuranoindoline-bearing heptacyclic fungal RiPPs with anticancer activities

News Publication Date: 23-Jun-2025

Web References:
https://www.nature.com/articles/s41589-025-01946-9

References:
Based on the results presented herein, a provisional patent application (RICE.P0154US.P1) has been filed through Rice University.

Image Credits: Bella Ciervo

Keywords

Aspergillus flavus, fungal RiPPs, asperigimycins, cancer therapy, leukemia, cyclic peptides, ribosomally synthesized peptides, post-translational modifications, microtubule inhibition, SLC46A3, natural products, drug discovery